Biopharmaceutical research companies are conducting or have conducted more than 3,200 clinical trials of new medicines in collaboration with the state’s clinical research centers, university medical schools and hospitals (1999 to present).
Of the more than 3,200 clinical trials, 1,679 target the nation’s six most debilitating chronic diseases— asthma, cancer, diabetes, heart disease, mental illnesses and stroke.
“We need to make more patients and doctors in South Carolina aware of local community clinical trials of new medicines. The fact is, we know that some chronic disease sufferers are still seeking treatments that are best for them and a clinical trial of a new drug, for some, could be a good therapeutic option to explore and discuss with their doctors. It’s important, very important, that nearly 300 trials of new chronic disease treatments in the state are still active and seeking patient recruits. Those trials include 178 tests of new cancer medicines, 31 tests of new diabetes drugs and 23 of new heart disease medications.” --Paul Jeter, Executive Director, Leukemia & Lymphoma Society, South Carolina Chapter